Histiocytoid sweet’s syndrome: A localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease

European Journal of Dermatology

Volumn 25, Issue 4, 2015, Pages 335-341

  Magro, Cynthia M ^a   Momtahen, Shabnam ^a   Nguyen, Giang H ^b   Wang, Xuan ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Clonal cutaneous monocytosis; Histiocytoid sweet s syndrome; Sweet s syndrome

Indexed keywords

CD123 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CD68 ANTIGEN; CD83 ANTIGEN; CYCLOOXYGENASE 2 INHIBITOR; GLYCOPROTEIN P 15095; MYELOPEROXIDASE; MYXOVIRUS RESISTANCE PROTEIN A; BLOOD DENDRITIC CELL ANTIGEN 3, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN; MX1 PROTEIN, HUMAN; MYXOVIRUS RESISTANCE PROTEIN; ONCOPROTEIN; PEROXIDASE; TCL1A PROTEIN, HUMAN;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOGENETICS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MACROPHAGE; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL; PHENOTYPE; RASH; SKIN BIOPSY; TCL1 ONCOGENE; VERY ELDERLY; ACUTE MYELOBLASTIC LEUKEMIA; CHEMISTRY; COMPLICATION; DENDRITIC CELL; HISTIOCYTE; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD11C; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, SURFACE; DENDRITIC CELLS; FEMALE; GPI-LINKED PROTEINS; HISTIOCYTES; HUMANS; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; MYXOVIRUS RESISTANCE PROTEINS; NEUTROPHILS; PEROXIDASE; PHENOTYPE; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, IGG; SWEET SYNDROME; YOUNG ADULT;

EID: 84941775451     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2015.2586     Document Type: Article

References (33)

1. Requena L, Kutzner H, Palmedo G, et al. Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol 2005; 141: 834-842.
2. Bilgili SG, Karadag AS, Calka O, Bulut G. Histiocytoid Sweet syndrome. Int J Dermatol. 2014; 53: e80-e82.
3. Lin J, Zhang Q, Chen M. Subcutaneous histiocytoid Sweet’s syndrome in a patient associated with myelodysplastic syndromerefractory anemia. J Dermatol 2012; 39: 99-101.
4. Wilson TC, Stone MS, Swick BL. Histiocytoid Sweet SyndromeWith Haloed Myeloid Cells Masquerading as a Cryptococcal Infection. Am J Dermatopathol 2014; 36: 264-269.
5. Park JY, Park JS, Kim YC. Histiocytoid Sweet’s syndrome potentially related to decitabine in a patient with myelodysplastic syndrome. Eur J Dermatol 2012; 22: 811-812.
6. Zhenying Z, Xiaoming L, Yongjun P, Shixin H. A case of leukemia cutis presenting as histiocytoid Sweet’s syndrome. Int J Dermatol 2013; 52: 1338-1341.
7. Hünermund A, Wendel AM, Geissinger E, Brö Gei EB, Stoevesandt J. Typically atypical: histiocytoid Sweet syndrome, associated with malignancy. J Dtsch Dermatol Ges 2011; 9: 666-669.
8. Apalla Z, Kanatli L, Sotiriou E, Manousari A, Papagarifallou I, Calonje E. Histiocytoid Sweet syndrome. Clin Exp Dermatol 2011; 36: 562-563.
9. Ten Oever J, Kuijper PH, Kuijpers AL, Dercksen MW, Vreugdenhil G. Complete remission of MDS RAEB following immunosuppressive treatment in a patient with Sweet’s syndrome. Neth J Med 2009; 67: 347-350.
10. Heymann WR. Histiocytoid Sweet syndrome. J Am Acad Dermatol 2009; 61: 693-694.
11. Liu CI, Hsiao CH, Wu JT, Tsai TF. Sweet syndrome with histiocytoid infiltrate and neutropenia:a rare combination. J Am Acad Dermatol 2009; 61: 882-884.
12. Murase JE, Wu JJ, Theate I, Cole GW, Barr RJ, Dyson SW. Bortezomib-induced histiocytoid Sweet syndrome. J Am Acad Dermatol 2009; 60: 496-497.
13. Kim JS, Roh HS, Lee JW, Lee MW, Yu HJ. Distinct variant of Sweet’s syndrome: bortezomib-induced histiocytoid Sweet’s syndrome in a patient with multiple myeloma. Int J Dermatol 2012; 51: 1491-1493.
14. Llamas-Velasco M, Concha Garzón MJ, Fraga J, Arag SM. Histiocytoid sweet syndrome related to bortezomib: A mimicker of cutaneous infiltration by myeloma. Indian J Dermatol Venereol Leprol 2015 [Epub ahead of print].
15. Kaiser R, Connolly K, Linker C, Maldonado J, Fye K. Stem cell transplant for myelodysplastic syndrome-associated histiocytoid Sweet’s syndrome in a patient with arthritis and myalgias. Arthritis Rheum 2008; 59: 1832-1834.
16. Camarillo D, McCalmont TH, Frieden IJ, Gilliam AE. Two pediatric cases of nonbullous histiocytoid neutrophilic dermatitis presenting as a cutaneous manifestation of lupus erythematosus. Arch Dermatol 2008; 144: 1495-1498.
17. Spencer B, Nanavati A, Greene J, Butler DF. Dapsone-responsive histiocytoid Sweet’s yndrome associated with Crohn’s disease. J Am Acad Dermatol 2008; 59(2 Suppl 1): S58-S60.
18. Wu AJ, Rodgers T, Fullen DR. Drug-associated histiocytoid Sweet’s syndrome: a true neutrophilic maturation arrest variant. J Cutan Pathol 2008; 35: 220-224.
19. Chow S, Pasternak S, Green P, et al. Histiocytoid neutrophilic dermatoses and panniculitides: variations on a theme. Am J Dermatopathol 2007; 29: 334-341.
20. Kasuya A, Fujiyama T, Hashizume H, Inuzuka M, Tokura Y. Histiocytoid Sweet’s syndrome associated with t(9;22)(q34;q11)-positive chronic myelogenous leukemia: immature granulocytic origin of histiocytic cells. Int J Dermatol 2013; 52: 1577-1579.
21. Pinal-Fernandez I, Ferrer Fabrega B, Ramentol Sintas M, Solans Laque R. Histiocytoid Sweet syndrome and cutaneous polyarteritis nodosa secondary to myelodysplastic syndrome. Int J Rheum Dis 2013; 16: 777-779.
22. Chavan RN, Cappel MA, Ketterling RP, et al. Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization. J Am Acad Dermatol 2014; 70: 1021-1027.
23. Srisuttiyakorn C, Reeve J, Reddy S, Imaeda S, Lazova R. Subcutaneous histiocytoid Sweet’s syndrome in a patient with myelodysplastic syndrome and acute myeloblastic leukemia. J Cutan Pathol 2014; 41: 475-479.
24. Peroni A, Colato C, Schena D, Rongioletti F, Girolomoni G. Histiocytoid Sweet syndrome is infiltrated predominantly by M2-like macrophages. J Am Acad Dermatol 2015; 72: 131-139.
25. So JK, Carlos CA, Frucht CS, Cohen PR. Histiocytoid giant cellulitis-like Sweet’s syndrome: case report and review of the literature. Dermatol Online J 2015; 25: 21.
26. Gerami P, Guitart J. Panniculitis with histiocytoid/immature neutrophils is not limited to histiocytoid panniculitic Sweet syndrome. Am J Dermatopathol 2007; 29: 596.
27. Anzalone CL, Cohen PR. Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Curr Opin Hematol 2013; 20: 26-35.
28. Jo MS, Lim YB, Shin HK, Choe J, Seul JH, Jang TJ. A Case Report of Sweet’s Syndrome with Parotitis. Arch Plast Surg 2012; 39: 59-62.
29. Wang X, Magro CM. Nine Cases of Histiocytoid Sweet’s Syndrome. Modern Pathology 2013; 26: 124A.
30. Barros MH, Hauck F, Dreyer JH, Kempkes B, Niedobitek G. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS One 2013; 8: e80908.
31. Jongbloed SL, Kassianos AJ, McDonald KJ, et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010; 207: 1247-1260.
32. Magro CM, De Moraes E, Burns F. Sweet’s syndrome in the setting of CD34-positive acute myelogenous leukemia treated with granulocyte colony stimulating factor: evidence for a clonal neutrophilic dermatosis. J Cutan Pathol 2001; 28: 90-96.
33. Magro CM, Kiani B, Li J, Crowson AN. Clonality in the setting of Sweet’s syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease. J Cutan Pathol 2007; 34: 526-534.